<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02088554</url>
  </required_header>
  <id_info>
    <org_study_id>PERIGON</org_study_id>
    <nct_id>NCT02088554</nct_id>
  </id_info>
  <brief_title>PERIGON Pivotal Trial</brief_title>
  <acronym>PERIGON</acronym>
  <official_title>Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, interventional, non-randomized, worldwide, multi-center trial, with&#xD;
      each site following a common protocol. A maximum of 1300 subjects will be implanted at a&#xD;
      maximum of 40 sites in the US, Europe and Canada. The trial will include male and female&#xD;
      patients of legal age to provide informed consent in the country where they enroll in the&#xD;
      trial, requiring replacement for a diseased, damaged, or malfunctioning native or prosthetic&#xD;
      aortic valve. Subjects will be followed out to 5 years and select sites will follow subjects&#xD;
      out to 12 years. Enrollment is currently open to capture additional data sets for the size&#xD;
      29mm valve only.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 12, 2014</start_date>
  <completion_date type="Anticipated">December 31, 2035</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the safety of the Model 400 valve with regard to valve-related adverse events and death.</measure>
    <time_frame>Patients are followed through 5yrs</time_frame>
    <description>Safety of the valve will be evaluated by the time-related incidence of valve-related adverse events and death. The following valve-related adverse events will be evaluated in this study: Thromboembolism, Thrombosis, Hemorrhage, Paravalvular leak (PVL), Endocarditis, Hemolysis, Structural valve deterioration, Non-structural dysfunction, Reintervention, Explant, and Death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Confirm the effectiveness of the Model 400 valve, with regard to NYHA Functional Classification and hemodynamic performance.</measure>
    <time_frame>Patients are followed through 5yrs</time_frame>
    <description>The effectiveness endpoints are:&#xD;
New York Heart Association Functional Classification (at discharge (or 30 days), 3-6 months, 1 year and annually thereafter through 5 years) as compared to Baseline.&#xD;
Clinically acceptable Hemodynamic Performance (at discharge (or 30 days), 3-6 months, 1 year and annually thereafter through 5 years) confirmed by core lab evaluation of echocardiography.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1290</enrollment>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Model 400 aortic valve bioprosthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Model 400 aortic valve bioprosthesis</intervention_name>
    <arm_group_label>Model 400 aortic valve bioprosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient has moderate or greater aortic stenosis or regurgitation, and there is&#xD;
             clinical indication for replacement of their native or prosthetic aortic valve with a&#xD;
             bioprosthesis, with or without concomitant procedures, which are limited to any of the&#xD;
             following:&#xD;
&#xD;
             i. LAA ligation ii. CABG iii. PFO closure iv. Ascending aortic aneurysm or dissection&#xD;
             repair not requiring circulatory arrest v. Resection of a sub-aortic membrane not&#xD;
             requiring myectomy&#xD;
&#xD;
          2. Patient is geographically stable and willing to return to the implanting site for all&#xD;
             follow-up visits&#xD;
&#xD;
          3. Patient is of legal age to provide informed consent in the country where they enroll&#xD;
             in the trial&#xD;
&#xD;
          4. Patient has been adequately informed of risks and requirements of the trial and is&#xD;
             willing and able to provide informed consent for participation in the clinical trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient has a pre-existing prosthetic valve or annuloplasty device in another position&#xD;
             or requires replacement or repair of the mitral, pulmonary or tricuspid valve&#xD;
&#xD;
          2. Patient has had previous implant and then explant of the Model 400 aortic valve&#xD;
             bioprosthesis&#xD;
&#xD;
          3. Patient presents with active endocarditis, active myocarditis or other systemic&#xD;
             infection&#xD;
&#xD;
          4. Patient has an anatomical abnormality which would increase surgical risk of morbidity&#xD;
             or mortality, including:&#xD;
&#xD;
               -  Ascending aortic aneurysm or dissection repair requiring circulatory arrest&#xD;
&#xD;
               -  Acute Type A aortic dissection&#xD;
&#xD;
               -  Ventricular aneurysm&#xD;
&#xD;
               -  Porcelain aorta&#xD;
&#xD;
               -  Hostile mediastinum&#xD;
&#xD;
               -  Hypertrophic obstructive cardiomyopathy (HOCM)&#xD;
&#xD;
               -  Documented pulmonary hypertension (systolic &gt;60mmHg)&#xD;
&#xD;
          5. Patient has a non-cardiac major or progressive disease, with a life expectancy of less&#xD;
             than 2 years. These conditions include, but are not limited to:&#xD;
&#xD;
               -  Child-Pugh Class C liver disease&#xD;
&#xD;
               -  Terminal cancer&#xD;
&#xD;
               -  End-stage lung disease&#xD;
&#xD;
          6. Patient has renal failure, defined as dialysis therapy or GFR&lt;30 mL/min/1.73 m2&#xD;
&#xD;
          7. Patient has hyperparathyroidism&#xD;
&#xD;
          8. Patient is participating in another investigational device or drug trial or&#xD;
             observational competitive study&#xD;
&#xD;
          9. Patient is pregnant, lactating or planning to become pregnant during the trial period&#xD;
&#xD;
         10. Patient has a documented history of substance (drug or alcohol) abuse&#xD;
&#xD;
         11. Patient has greater than mild mitral valve regurgitation or greater than mild&#xD;
             tricuspid valve regurgitation as assessed by echocardiography&#xD;
&#xD;
         12. Patient has systolic EF&lt;20% as assessed by echocardiography&#xD;
&#xD;
         13. Patient has Grade IV Diastolic Dysfunction&#xD;
&#xD;
         14. Patient has documented bleeding diatheses&#xD;
&#xD;
         15. Patient has had an acute preoperative neurological deficit or myocardial infarction&#xD;
             and has not returned to baseline or stabilized â‰¥30 days prior to enrollment&#xD;
&#xD;
         16. Patient requires emergency surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Sabik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Cleveland Medical Center (Not a recruiting site)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof. Dr. Robert Johannes Menno Klautz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leiden University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ryan Palmer</last_name>
    <phone>(763) 514-9732</phone>
    <email>ryan.j.palmer@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maggie Haltvick</last_name>
    <phone>(763) 526-1419</phone>
    <email>maggie.haltvick@medtronic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Southern California (USC) University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033-5313</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Stanford Hospitals and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045-2545</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Hagberg, MD</last_name>
    </contact>
    <investigator>
      <last_name>Robert Hagberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Shands</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Michigan Cardiovascular Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5853</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Himanshu Patel, MD</last_name>
    </contact>
    <investigator>
      <last_name>Himanshu Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407-1139</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Maimonides Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Adams, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York-Presbyterian Hospital/Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital (OhioHealth)</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>ProMedica Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Moront, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michael Moront, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Hospital</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Cardiothoracic and Vascular Surgeons (CTVS)</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756-4080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faraz Kerendi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Faraz Kerendi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Aurora Saint Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215-4330</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre - University Campus</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie de QuÃ©bec (IUCPQ)</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Cardiologique du Haut-LÃ©vÃªque</name>
      <address>
        <city>Bordeaux</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Bichat - Claude Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum KÃ¶ln - Anstalt des Ã¶ffentlichen Rechts</name>
      <address>
        <city>Cologne</city>
        <state>KÃ¶ln</state>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum MÃ¼nchen</name>
      <address>
        <city>Munich</city>
        <state>MÃ¼nchen</state>
        <zip>DE 80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-UniversitÃ¤t Frankfurt am Main</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig GmbH</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele - Milano</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Leids Universitair Medisch Centrum (LUMC)</name>
      <address>
        <city>Leiden</city>
        <zip>2333 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Erasmus MC</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Inselspital - UniversitÃ¤tsspital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsSpital ZÃ¼rich</name>
      <address>
        <city>ZÃ¼rich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Guy's &amp; St Thomas' NHS Foundation Trust - St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 4, 2014</study_first_submitted>
  <study_first_submitted_qc>March 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2014</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 13, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT02088554/Prot_003.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 3, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT02088554/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 4, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT02088554/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

